Sallie Mae Stock: $5.5M Stake Sale Sparks Concerns
💡 Key Takeaway
A fund's complete exit from SLM reflects credit normalization worries despite solid profitability.
What Happened
Helix Partners Management LP sold its entire 200,000-share stake in SLM Corporation (Sallie Mae) on February 13, 2026. The transaction was valued at approximately $5.54 million, eliminating the fund's 3.18% position in the education finance company.
This sale occurred against a backdrop of SLM's stock declining 14.6% over the past year, significantly underperforming the S&P 500 by 27.5 percentage points. The company's shares were trading at $24.76 just before the transaction was disclosed.
Despite the negative price action, SLM reported solid financial results for 2025, including $3.46 in GAAP diluted EPS and a 5.21% net interest margin. The company also authorized a new $500 million share repurchase program after buying back $373 million in shares last year.
The fund's portfolio restructuring reveals a concentrated strategy, with Core Scientific now representing over 50% of Helix Partners' assets under management. The sale reduced SLM from a 3.18% position to just 0.70% of the fund's portfolio.
What This Means for Me
Why It Matters
The complete exit by an institutional investor signals concerns about SLM's near-term growth prospects, particularly regarding credit quality. While the company remains profitable, rising delinquencies and expected charge-offs suggest headwinds ahead.
SLM's loan delinquencies increased to 4.0% of loans in repayment, up from 3.7% a year earlier. More importantly, management guided for $345-385 million in net charge-offs for 2026, indicating a normalization of credit conditions after years of unusually low defaults.
The education finance specialist faces a challenging environment where credit normalization could cap earnings growth. However, the company's strong capital position and ongoing share repurchases provide some downside protection for patient investors.
For the broader financial sector, this move highlights how institutional investors are repositioning portfolios amid changing credit conditions. The concentration in Helix's remaining holdings suggests a strategic shift toward different asset classes and risk profiles.
Stock to Watch
| Stocks | Impact | Analysis | |
|---|---|---|---|
| SLM | Negative | Institutional exit and rising delinquencies create near-term headwinds, though solid fundamentals provide some support. | |
| CORZ | Neutral | Mentioned as Helix's largest holding but no specific news about Core Scientific's fundamentals. |
Source: The Motley Fool
Analysis generated by Bobby AI quantitative model, reviewed and edited by our research team. This is not financial advice. Always do your own research before making investment decisions.
Bobby Insight
Hold for dividend income but wait for credit metrics to stabilize before adding positions.
SLM's profitability and capital returns provide foundation, but rising charge-offs suggest limited near-term upside. The institutional exit reflects legitimate concerns about credit normalization capping growth narratives.
What This Means for Me
Read More
SLM Q3: Strategic Shift, Lower Guidance, Long-Term Buy
Bullish SLM's strategic pivot to retain loans and diversify funding through the Sixth Street partnership supports long-term value, despite near-term earnings headwinds.
SLMSLMBPOct 23, 2026Sallie Mae (SLM) Posts Q3 Loss: What It Means for Investors
Neutral SLM's Q3 loss and revenue miss highlight ongoing challenges, but the stock's steep decline may already reflect much of the bad news, making it a hold for now.
SLMSLMBPECPGOct 22, 2026Allegion Raises Guidance: A Long-Term Buy Signal
Bullish Allegion's raised guidance and pricing power make it a compelling long-term investment, driven by secular trends in electronic access and data center construction.
ALLEOct 23, 2026